Synopsis of the 6th walker's cay colloquium on cancer vaccines and immunotherapy

W. Martin Kast, Hyam Levitsky, Francesco M. Marincola

Research output: Contribution to journalArticlepeer-review

Abstract

The 6th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay was held under the auspices of the Albert B. Sabin Vaccine Institute on March 10-13, 2004. The Colloquium consisted of a select group of 34 scientists representing academia, biotechnology and pharmaceutical industry. The main goal of this gathering was to promote in a peaceful and comfortable environment exchanges between basic and clinical science. The secondary benefit was to inspire novel bench to bedside ventures and at the same time provide feed back about promising and/or disappointing clinical results that could help re-frame some scientific question or guide the design of future trials. Several topics were covered that included tumor antigen discovery and validation, platforms for vaccine development, tolerance, immune suppression and tumor escape mechanisms, adoptive T cell therapy and dendritic cell-based therapies, clinical trials and assessment of response. Here we report salient points raised by speakers or by the audience during animated discussion that followed each individual presentation.

Original languageEnglish (US)
Article number20
JournalJournal of Translational Medicine
Volume2
DOIs
StatePublished - Jun 22 2004

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Synopsis of the 6th walker's cay colloquium on cancer vaccines and immunotherapy'. Together they form a unique fingerprint.

Cite this